I now have comprehensive content. Let me compile the full structured answer from Robbins.
Skin Tumours - Robbins & Cotran Pathologic Basis of Disease
(Chapter 25 - The Skin)
OVERVIEW - Classification
| Category | Tumours |
|---|
| Disorders of Pigmentation & Melanocytes | Freckle, Lentigo, Melanocytic Nevus, Dysplastic Nevi, Melanoma |
| Benign Epithelial Tumours | Seborrheic Keratosis, Acanthosis Nigricans, Fibroepithelial Polyp, Epithelial/Follicular Inclusion Cyst |
| Adnexal (Appendage) Tumours | Cylindroma, Syringoma, others |
| Premalignant & Malignant Epidermal Tumours | Actinic Keratosis, Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma |
| Tumours of the Dermis | Benign Fibrous Histiocytoma (Dermatofibroma), Dermatofibrosarcoma Protuberans |
| Tumours of Cellular Migrants to the Skin | Mycosis Fungoides (CTCL), Mastocytosis |
I. DISORDERS OF PIGMENTATION & MELANOCYTES
1. Freckle (Ephelis)
- Most common pigmented lesion of childhood in lightly pigmented individuals
- Small (1 mm to several mm), tan-red or light brown macules appearing after sun exposure
- Morphology: Hyperpigmentation results from increased melanin in basal keratinocytes - melanocytes are normal in density (may be slightly enlarged)
- Fade in winter, darken in summer - due to changes in degree of pigmentation, NOT number of melanocytes
- Note: Café au lait spots of neurofibromatosis type 1 resemble freckles histologically but are larger, arise independently of sun, and contain macromelanosomes
2. Lentigo
- Common benign localised hyperplasia of melanocytes
- Equal in both sexes, all skin types; most common in infants and children
- Small (5-10 mm), oval, tan-brown macules or patches; can involve mucous membranes
- Morphology: Linear (nonnested) melanocytic hyperplasia restricted to the cell layer immediately above the basement membrane - produces a hyperpigmented basal cell layer
- Unlike freckles, lentigines do NOT darken on sun exposure
3. Melanocytic Nevus (Pigmented Nevus / Mole)
Pathogenesis:
- Benign neoplasms associated with acquired activating mutations in RAS or BRAF (the kinase immediately downstream of RAS)
- Oncogene-induced senescence: the initial activating mutation causes a burst of proliferation followed by permanent cell cycle arrest - this is why nevi grow to a certain size and stop
Types (Table 25.2 summary):
| Type | Location of Nevus Cells | Features |
|---|
| Junctional nevus | Dermoepidermal junction | Flat, brown; nests of melanocytes at DEJ |
| Compound nevus | DEJ + dermis | Slightly raised; nests at both locations |
| Intradermal nevus | Dermis only | Raised, dome-shaped; most common type in adults; nests entirely in dermis |
| Blue nevus | Deep dermis | Slate-blue colour due to Tyndall effect; spindle-shaped melanocytes deep in dermis |
| Spitz nevus | Compound (usually) | Large epithelioid/spindle cells; mostly in children; often confused with melanoma |
| Congenital nevus | Compound/intradermal | Present at birth; large congenital nevi have increased risk of melanoma |
| Dysplastic nevus | Compound | Irregular borders, variegated colour; see below |
Morphology of common acquired nevus:
- Small (<6 mm), rounded, well-demarcated lesion with uniform pigmentation
- Early: nests of round-to-oval nevus cells at DEJ (junctional component)
- Progression: cells drop off into dermis; junctional activity disappears with age
- Mature intradermal nevi: upper dermal cells may be large and pigmented; deeper cells smaller, spindle-shaped, may form neural-like structures ("neurotization")
- Maturation (cells smaller with depth) distinguishes benign nevi from melanoma
4. Dysplastic Nevi
Key features:
- Larger than common acquired nevi (>5 mm, often >10 mm)
- Irregular, pebbly surface; variable pigmentation; irregular, indistinct borders
- May occur sporadically or in familial clusters (Familial Dysplastic Nevus Syndrome / B-K mole syndrome)
- Patients with familial dysplastic nevi + family history of melanoma have a nearly 100% lifetime risk of developing melanoma
Morphology:
- Architectural disorder: nests of melanocytes that bridge adjacent rete ridges (confluent growth)
- Cytologic atypia: enlarged melanocytes with abundant cytoplasm and large nuclei with prominent nucleoli
- Stromal reaction: lamellar fibroplasia around elongated rete ridges and lymphocytic infiltrate
- Lentiginous proliferation: single melanocytes proliferating along the basal layer beyond the lateral margins of the compound component ("shouldering")
5. Melanoma
One of the most aggressive human malignancies - incidence rising steadily.
Pathogenesis:
| Mutation | Frequency | Significance |
|---|
| BRAF (V600E) | ~60% of melanomas | Activates MAPK; targetable with vemurafenib |
| NRAS | ~20% | Activates both MAPK and PI3K/AKT |
| NF1 loss | ~15% | Upstream RAS activator; often in older patients |
| KIT | <5% | Acral/mucosal melanomas; targetable |
| CDKN2A (p16/p14ARF) | Common | Tumour suppressor; lost in many melanomas |
| TERT promoter | >70% | Maintains telomere length |
- UV radiation is the main environmental cause; C→T transitions at dipyrimidine sites are the UV mutational signature
- UV suppresses cutaneous immunity (transient defect in innate immunity), reducing elimination of sun-damaged cells
ABCDE warning signs:
- Asymmetry
- Border irregularity
- Color variation (shades of brown, black, red, white, blue)
- Diameter >6 mm
- Evolution (change over time)
Growth phases:
- Radial growth phase (RGP): Horizontal spread within epidermis and superficial dermis; low metastatic potential; melanoma cells lack ability to form tumour masses in dermis
- Vertical growth phase (VGP): Invasion into deeper dermis as an expanding mass; acquisition of metastatic potential; cells have different antigenic profile from RGP cells
Morphological types:
| Type | Features |
|---|
| Superficial spreading melanoma | Most common (~70%); prolonged RGP; anywhere on body |
| Lentigo maligna melanoma | On sun-damaged skin of elderly; longest RGP (years-decades) |
| Nodular melanoma | Predominantly VGP from outset; darkly pigmented nodule; most aggressive |
| Acral lentiginous melanoma | Palms, soles, subungual; most common type in dark-skinned individuals; BRAF mutations less common; KIT mutations more common |
Morphology:
- Radial growth: atypical melanocytes (large cells, prominent red nucleoli, irregular nuclear contours) spreading upward (pagetoid spread) and laterally
- Vertical growth: nodular aggregates of cells with mitotic figures invading dermis
- Regression areas: fibrosis, melanophages, lymphocytes
Prognosis - Breslow thickness (most important prognostic factor):
| Breslow Thickness | 5-year Survival |
|---|
| <0.76 mm | ~98% |
| 0.76-1.5 mm | ~85% |
| 1.5-4 mm | ~57% |
| >4 mm | ~50% |
Other prognostic factors: mitotic rate, ulceration, sentinel lymph node status, presence of tumour-infiltrating lymphocytes.
II. BENIGN EPITHELIAL TUMOURS
6. Seborrheic Keratosis
- Extremely common, usually in older individuals; rarely seen before age 30
- Appear suddenly in large numbers (Leser-Trélat sign) may indicate internal malignancy (usually GI adenocarcinoma)
Morphology:
- Round, flat-to-raised coin-like lesions with a "stuck-on" greasy appearance; tan to dark brown; sharply demarcated
- Microscopically: proliferation of basaloid (basosquamous) cells with variable melanin; formation of keratin-filled cysts (horn cysts) and pseudo-horn cysts (invaginations of surface keratin)
- Dermatosis papulosa nigra: a variant seen in ~1/3 of African American adults (clinically and histologically identical to seborrheic keratosis)
- Pathogenesis: activating mutations in FGFR3 (identical receptor mutated in achondroplasia) and/or PIK3CA in most sporadic lesions; FGFR3 also mutated in acanthosis nigricans
7. Acanthosis Nigricans
- Thickened, hyperpigmented, velvety skin in flexural areas (axillae, neck folds, groin, anogenital)
- Two types:
- Benign (~80%): childhood/puberty onset; associated with obesity, diabetes (hyperinsulinemia → IGF1R activation), endocrine tumours, or autosomal dominant inheritance (FGFR3 germline mutation)
- Malignant (~20%): middle-aged/older; paraneoplastic - most commonly with GI adenocarcinoma (possibly via TGF-α → EGFR activation)
- Morphology: Undulating epidermal peaks and valleys (papillomatosis), hyperkeratosis, slight basal layer hyperpigmentation - NO melanocytic hyperplasia
8. Fibroepithelial Polyp (Acrochordon / Skin Tag / Squamous Papilloma)
- One of the most common cutaneous lesions; middle-aged and older individuals
- Soft, flesh-coloured polypoid growths on neck, axillae, eyelids, groin
- Covered by normal-appearing epidermis; fibrovascular core
9. Epithelial/Follicular Inclusion Cyst
- Intradermal or subcutaneous cyst lined by stratified squamous epithelium containing laminated keratin
- Rupture causes intense foreign-body inflammatory reaction
III. ADNEXAL (APPENDAGE) TUMOURS
Arise from hair follicles, sweat glands, or sebaceous glands. Generally benign but malignant variants exist.
- Cylindroma: lobules of basaloid cells in a "jigsaw puzzle" pattern; thought to arise from eccrine or apocrine glands
- Syringoma: small ducts lined by flattened epithelium in a dense fibrous stroma; eccrine differentiation; common on lower eyelids
- Most adnexal tumours are benign and locally excised
IV. PREMALIGNANT & MALIGNANT EPIDERMAL TUMOURS
10. Actinic Keratosis (Solar Keratosis)
- The most common precancerous skin lesion; risk of progression to SCC is low for any individual lesion but significant in aggregate
- Caused by UV-induced DNA damage; strongly associated with cumulative sun exposure in lightly pigmented individuals
- Morphology:
- Sandpaper-like rough, scaly erythematous lesions on sun-exposed areas
- Atypical (dysplastic) keratinocytes in the lower epidermis with cytoplasmic pink (dyskeratotic) cells, alternating ortho- and parakeratosis
- Elastosis (solar elastosis) in the dermis
- Atypia confined to the lower portion of the epidermis (unlike full-thickness change of CIS/Bowen disease)
- Bowenoid actinic keratosis: full-thickness epidermal atypia = carcinoma in situ (Bowen disease)
11. Squamous Cell Carcinoma (SCC) of Skin
Second most common tumour on sun-exposed sites (after BCC).
Risk factors:
- UV radiation (most important) - TP53 mutations at pyrimidine dimers are early events
- Immunosuppression (chemotherapy, organ transplantation) - reduces surveillance; HPV subtypes 5 & 8 suspected
- Industrial carcinogens (tars, oils)
- Chronic ulcers, burn scars, draining osteomyelitis
- Arsenical ingestion
- Ionizing radiation
- Xeroderma pigmentosum (defective nucleotide excision repair → rapid mutation accumulation)
- Oral: tobacco, betel nut chewing
Genetics: TP53 (early), RAS activation, Notch signalling loss
Morphology:
- In situ (Bowen disease): sharp, red, scaling plaques; full-thickness epidermal atypia - atypical cells with enlarged hyperchromatic nuclei at ALL levels of epidermis
- Invasive: nodular lesions, variable keratin production (hyperkeratotic scale), may ulcerate
- Variable differentiation: well-differentiated forms make keratin pearls (squamous eddies); poorly differentiated forms show anaplastic cells with rare keratinization
- Desmosomes (intercellular bridges) may be identified
Prognosis: <5% metastasize to regional nodes (far lower than oral/pulmonary SCC), but causes ~8000 deaths/year in the US (similar to metastatic melanoma) due to sheer frequency
12. Basal Cell Carcinoma (BCC)
Most common human malignancy. Locally aggressive but almost never metastasizes.
Pathogenesis:
- UV radiation + Hedgehog (HH) signalling pathway is central
- Loss of PTCH1 (Patched) function → constitutive activation of Smoothened (SMO) → Gli transcription factor activation
- PTCH1 mutations in ~90% of sporadic BCCs (often UV signature mutations)
- Gorlin syndrome (Basal Cell Nevus Syndrome): germline PTCH1 mutation → hundreds of BCCs, jaw cysts, skeletal anomalies, medulloblastoma
- Hedgehog inhibitor vismodegib (SMO inhibitor) is effective in advanced BCC
Morphology:
- Arise on hair-bearing skin; most on face (nose most common site)
- Pearly or translucent papules with telangiectatic vessels; may show central ulceration ("rodent ulcer")
- Microscopically: nests of basaloid cells with large oval nuclei and scant cytoplasm arising from the epidermis
- Characteristic peripheral palisading of nuclei in tumour nests + retraction artefact (clefting) between tumour nests and stroma
- Stromal mucin between tumour nests
- Subtypes: nodular (most common), superficial, morpheaform/sclerosing (most aggressive - infiltrative cords in a dense fibrous stroma; high recurrence)
13. Merkel Cell Carcinoma
- Rare but highly aggressive neuroendocrine carcinoma of the skin
- Arises from Merkel cells (mechanoreceptors in basal epidermis) or their precursors
- Associated with Merkel cell polyomavirus (MCV) integration in ~80% of cases; UV-related TP53 mutations in most MCV-negative cases
- Seen predominantly in elderly, immunocompromised patients
- Morphology: Small blue cells with scant cytoplasm, vesicular nuclei, numerous mitoses; perinuclear dot-like cytokeratin 20 (CK20) positivity on immunostaining (paranuclear dot pattern - pathognomonic)
- High rates of lymph node metastasis; poor prognosis
V. TUMOURS OF THE DERMIS
14. Benign Fibrous Histiocytoma (Dermatofibroma)
- Common benign dermal tumour; most common on legs of women
- Triggered by minor trauma or insect bite in some cases
- Morphology: Firm, tan-brown papule/nodule; overlying epidermis often hyperpigmented
- Histology: whorled proliferation of spindle-shaped fibroblasts/histiocytes with collagen trapping at the periphery
- Overlying epidermis shows basilar hyperpigmentation and pseudoepitheliomatous hyperplasia
- "Dirty finger" pattern - irregular collagen trapping
15. Dermatofibrosarcoma Protuberans (DFSP)
- Low-grade malignant fibrous tumour of the dermis; locally aggressive, rarely metastasizes
- Pathogenesis: characteristic translocation t(17;22) creating COL1A1-PDGFB fusion gene → constitutive PDGFR-β signalling; imatinib (PDGFR inhibitor) is effective in unresectable cases
- Morphology:
- Indurated, flesh-coloured plaque that may develop protuberant nodules
- On sectioning: firm, fibrotic nodule
- Histology: storiform (cartwheel/swirling) pattern of spindled cells
- Infiltrates subcutis in a "Swiss cheese" pattern (tumour cords surrounding fat lobules) - accounts for high local recurrence after simple excision
VI. TUMOURS OF CELLULAR MIGRANTS TO THE SKIN
16. Mycosis Fungoides (Cutaneous T-Cell Lymphoma / CTCL)
- Lymphoma of skin-homing CD4+ helper T cells; part of a spectrum of CTCLs
- Most commonly affects persons >40 years old; involves truncal areas
Clinical stages:
- Eczema-like patches - scaly, red-brown patches (early; may persist for years)
- Plaques - raised, scaling, indurated erythematous plaques resembling psoriasis
- Tumour nodules - fungating, may ulcerate; correlates with systemic spread
Morphology:
- Infiltrate of atypical lymphocytes accumulating beneath and invading the epidermis
- Pautrier microabscesses: small intraepidermal aggregates of atypical lymphocytes (pathognomonic)
- Atypical cells have highly convoluted ("cerebriform") nuclei
Immunophenotype: CD4+, CLA+ (cutaneous lymphocyte antigen - responsible for skin homing); aberrant loss of pan-T-cell antigens (CD7 most commonly lost); clonal TCR gene rearrangements
Sézary syndrome: leukemic phase of CTCL - circulating neoplastic T cells (Sézary cells with cerebriform nuclei) + erythroderma
Treatment: topical steroids/UV for early lesions; systemic chemotherapy for advanced disease
17. Mastocytosis
- A spectrum of disorders characterised by accumulation of mast cells in the skin and other organs
- Most common form: urticaria pigmentosa - multiple small, reddish-brown macules and papules that urticate when rubbed (Darier sign - localized urticaria/whealing on stroking a lesion)
- Pathogenesis: Majority caused by activating mutations in c-KIT (CD117), the receptor for stem cell factor (SCF), which is the major growth factor for mast cells; most common mutation is D816V point mutation in KIT
- Morphology: Dense dermal infiltrates of mast cells with round/oval nuclei and abundant pale cytoplasm; metachromatic granules on Giemsa stain; CD117+ on immunohistochemistry
- Systemic mastocytosis can involve bone marrow, liver, spleen; may cause mediator release symptoms (flushing, hypotension, GI symptoms)
Key Comparison Table: BCC vs SCC vs Melanoma
| Feature | BCC | SCC | Melanoma |
|---|
| Origin | Basal cells of epidermis | Squamous keratinocytes | Melanocytes |
| Most common site | Face (nose) | Sun-exposed (face, hands) | Any site (back in men, legs in women) |
| Key driver | PTCH1/HH pathway | TP53, RAS | BRAF V600E (~60%) |
| Metastasis | Almost never | <5% (skin SCC) | Common; early |
| Prognosis | Excellent | Good if caught early | Depends on Breslow depth |
| Key histology | Peripheral palisading + retraction | Keratin pearls, intercellular bridges | Pagetoid spread, VGP |
| Special association | Gorlin syndrome (germline PTCH1) | Xeroderma pigmentosum, immunosuppression | Dysplastic nevi, CDKN2A germline |
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, Chapter 25 - The Skin